Tag: biosimilars

Global Biosimilar Markets: Europe vs United States

Europe led the world in biosimilar adoption with clear regulations and strong uptake since 2006. The U.S. lagged due to legal and systemic barriers but is now accelerating after key FDA policy changes in 2024. Both markets are growing fast, with biosimilars poised to cut biologic drug costs significantly.

Clinical Outcomes with Biosimilars: Do They Work as Well as the Original Biologics?

Biosimilars are highly similar to original biologics and have been proven in over 300 real-world studies to work just as well. They’re safer, cheaper, and increasingly the standard of care.

Tag: biosimilars

Global Biosimilar Markets: Europe vs United States

Clinical Outcomes with Biosimilars: Do They Work as Well as the Original Biologics?

About

Menu